ZHOU Cai-chun, XU Chong-rui. Gemcitabine-Based Chemotherapy with in Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(1): 26-27. DOI: 10.3969/j.issn.1671-5144.2010.01.012
|
Citation:
|
ZHOU Cai-chun, XU Chong-rui. Gemcitabine-Based Chemotherapy with in Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(1): 26-27. DOI: 10.3969/j.issn.1671-5144.2010.01.012
|
ZHOU Cai-chun, XU Chong-rui. Gemcitabine-Based Chemotherapy with in Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(1): 26-27. DOI: 10.3969/j.issn.1671-5144.2010.01.012
|
Citation:
|
ZHOU Cai-chun, XU Chong-rui. Gemcitabine-Based Chemotherapy with in Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2010, 10(1): 26-27. DOI: 10.3969/j.issn.1671-5144.2010.01.012
|
DownLoad: